The antigenic characteristics of eight human strains and two bovine strains, one of which is represented by two plaque variants, of parainfluenza virus type 3 were analysed. The strains and variants were compared using 52 monoclonal antibodies against five, two, six and six epitopes of the haemagglutinin neuraminidase (HN), fusion, nucleocapsid and matrix viral proteins respectively, employing radioimmunoprecipitation and immunofluorescence assays. The human strains, seven of which were isolated over 6 years at different geographical locations and the eighth one representing an older prototype strain, showed very little antigenic variation. Extensive differences were detected in all four proteins examined between the human strains and the two strains of bovine origin. Two bovine variants were less effectively neutralized than the prototype human strain with a series of monoclonal antibodies against the HN protein.
INTRODUCTION
The parainfluenza virus (PIV) types 1 to 4 belong to the paramyxovirus genus of the Paramyxoviridae (Kingsbury et al., 1978) . All four types cause respiratory tract disease in humans. The PIV type 3 (PIV-3) is the most common and causes more severe disease than the other three types. This virus can cause interstitial pneumonia in infants but in adults the symptoms are generally minor and confined to the upper respiratory tract (Wenzel et al., 1972) . Parainfluenza virus type 3 strains can also cause respiratory disease in cattle (Frank & Marshall, 1973; Reisinger et al., 1959) .
Immunity to the parainfluenza viruses seems to be short-lived (Glezen et al., 1984) and reinfections with the same types may occur within short time intervals Muchmore et al., 1981) . This does not seem to be due to antigenic instability as in the case of influenza virus but rather to be the result of a poor immunological response in the respiratory tract (Yanagihara & Mclntosh, 1980) . Antigenic variation within PIV types, however, may partially contribute to the efficacy of post-infection immunity and possibly relate to differences in virulence between various isolates (Shibuta et al., 1982 (Shibuta et al., , 1985 .
Differences have been demonstrated in the haemagglutinin-neuraminidase (HN) protein among human strains of PIV-3 (van Wyke Coelingh et al., 1985) and also differences in the HN protein between human and bovine strains (Abinanti et al., 1961 ; Coelingh et al., 1986; Ray & Compans, 1986) . Studies on strains of bovine PIV-3 in mice have shown differences in pathogenicity between plaque isolates (variants) of the YN strain (Shibuta et al., 1985) . The SC-YN variant and 91 ON strain induce a non-lethal hydrocephalus when inoculated intracerebrally in newborn mice but the M-YN variant causes a lethal brain disease (Shibuta et al., 1982) .
Monoclonal antibodies (MAbs) directed against viral proteins have been invaluable for structural analysis of viral proteins and for detection of antigenic differences within monotypic , antibodies 2223, 4584, 3285, 4795, 4477, 4492, 4771, 4703, 3253, 3477 and 4854; lane 12, mol. wt. markers. The high mol. wt. band in (a), lane 7, is interpreted to be a dimer of the HN protein. t Epitope group determined by competition ELISA (Rydbeck et al., 1986b) .
:~ + / + , Reaction in IF tests and RIPA respectively. Positive reaction is represented by +, negative by -and weak by w. Table 1 .
not react with one or more of the bovine strains and variants in the IF test or RIPA. The bovine strains and variants showed similar antigenic patterns although some differences were found among these three (Table 1) . The eight MAbs to the F protein reacted with all human strains in both IF and RIPA except antibody 4519 which only reacted weakly with strain VG 6239 in IF (Table 2) . Five of the eight anti-F antibodies reacted only weakly or not at all with the bovine strains and variants. The different reaction pattern of antibodies 3283 and 4503 shows that antibodies defined to react with the same epitope by competition ELISA apparently can identify different epitopes. Two MAbs possessing haemolysis inhibition activity, 3283 and 4673, reacted with all strains and variants, human and bovine.
Comparison of the HI and neutralizing capacity of MAbs against the HN protein using human
and bovine strains Only antibodies against the HN protein show marked neutralizing capacity (Rydbeck et al., 1986b) . Five neutralizing MAbs against four overlapping epitopes were tested in HI tests and NTs with the homologous human virus strain and two bovine virus variants. The reaction with homologous virus was two to 16 times higher in HI tests and eight to 32 times higher in NTs (Table 5) . A minimal difference in HI titres was seen with a polyclonal serum (K23), although this did show an eight-to 16-fold difference in neutralization of human strains and bovine variants.
Comparative analysis of the internal proteins NP and M
Of the 14 MAbs to the NP protein 10 reacted well with all human strains both in IF and RIPA (Table 3 ). Slight differences among the human strains could be detected with the remaining four antibodies which are directed to four epitope groups (Table 3) .
Seven antibodies against at least five different epitope groups of the NP protein showed some lack of reactivity with the bovine strains. Among these were antibodies 3482 and 4758 which also detected differences among the human strains.
Three of the 14 MAbs against the M protein detected differences among the human strains including one or more epitopes (Table 4) . Eight antibodies against at least six epitope groups varied in their reaction with the bovine strains and variants (Fig. 2) . Two antibodies 2873 and 4877 against different epitopes reacted with all strains and variants in both tests. Twelve antibodies differed in their reaction with human and bovine strains and variants; two of these did not react at all with any bovine strain or variant (Table 4) . Table 1 .
DISCUSSION
This study demonstrates with the aid of 52 MAbs against four different structural components that very little antigenic variation exists among human PIV-3 strains. The strains analysed were isolated during a time span of 5 years and were recovered from different geographical locations. The occasional variations observed did not correlate with either the temporal or geographical origin of strains.
A recent study (van Wyke Coelingh et al., 1985) demonstrated an apparently larger variation between strains in the HN glycoprotein than was found in this study. This may possibly be due antibodies 4637, 2873, 3471, 4723, 4733, 4468, 4659, 4816, 4684, 4782 and 4829; lane 12, mol . wt. markers. to the larger number of strains analysed, the more quantitative nature of the methods employed, i.e. HI and NT, or characteristics of the MAbs used. This is also reflected by the HI and NT results shown in Table 5 where low neutralization of the SC-YN and M-YN variants is observed with MAb 4630 which did not react in IF or RIPA (Table 1) . Corresponding studies with other paramyxoviruses have demonstrated small but distinct differences between strains of some of these monotypic viruses (Orvell et al., 1985; Rydbeck et al., 1986 a; Sheshberadaran et al., 1983) .
In contrast, studies of respiratory syncytial (RS) virus have demonstrated extensive antigenic differences and revealed the occurrence of two antigenic subgroups (Mufson et al., 1985) . These subgroups seem to have evolved separately, since within each one there appears to be minimal variation. The results of this study are, however, similar to the situation regarding human and bovine strains of RS virus which show distinct differences as well as large antigenic similarities (C. Orvell & E. Norrby, unpublished results). The bovine PIV-3 strain and variants were antigenically quite different from the human strains in all four proteins analysed. The two surface proteins, HN and F, exhibited similar differences between human and bovine strains and variants as did the two internal proteins NP and M. The present results agree with the findings of Ray & Compans (1986) in that the HN protein of human and bovine PIV-3 strains share an antigenic site, which is defined by antibodies showing HI and NT activity with the homologous human strain. Also Coelingh et al. (1986) reports three conserved antigenic sites of human and bovine strains, one of which is defined by neutralization and HI capacity. Limited antigenic differences have been found in the F protein of other paramyxoviruses (Orvell et al., 1985; Rydbeck et al., 1986a; Sheshberadaran et al., 1983) . This study shows some variation in the F protein of human and bovine strains and variants but the antibodies exhibiting haemolysis inhibition capacity reacted well with all strains and variants. This is possibly due to an essential function of these regions on the F protein, thus permitting little variability without functional disturbance.
The bovine variants SC-YN and M-YN have been shown to possess different encephalitogenic capacity in mice (Shibuta et al., 1982 (Shibuta et al., , 1985 . This might be a reflection of the differences detected between these two variants in the HN, M and possibly F proteins. Because of the occurrence of multiple differences, identification of one or more determinants responsible for the disease pattern cannot be achieved (L6ve et al., 1985, 1986) .
Division of some antigenic sites into more epitopes than were previously identified by competition assays is possible because of variable reactions of MAbs to the different viral strains. For example, the anti-F antibodies 4454, 4503 and 4549 were identical according to competition experiments (Rydbeck et al., 1986b) . The antigenic site they react with can be further divided into more than one epitope on the basis of the present results. Also by the same reasoning antigenic sites III and V of the NP protein can be subdivided into two epitopes each. Some differences between the two tests used, IF and RIPA, were observed. These differences may be due to methods of processing, such as fixation with acetone and detergent treatment of viral material. This emphasizes that more than one methodological approach is necessary for structural characterization of viral epitopes.
This study demonstrates limited but distinct variations among human PIV-3 strains. Such variations have to be considered in the selection of MAbs for diagnostic purposes. The pathogenetic significance of the limited antigenic variations detected remains to be explored.
